Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 24.6 | 23.6 | 22.6 | 22.0 | 22.0 | 23.2 | 27.0 | 25.6 |
| Revenue growth | 4.2% | 4.3% | 2.7% | 0.3% | -5.2% | -14.2% | 5.3% | 21.3% |
| Cost of goods sold | 2.9 | 3.2 | 3.3 | 3.7 | 3.5 | 3.6 | 3.9 | 4.7 |
| Gross profit | 21.7 | 20.4 | 19.3 | 18.3 | 18.5 | 19.6 | 23.0 | 21.0 |
| Gross margin | 88.3% | 86.5% | 85.4% | 83.0% | 84.1% | 84.4% | 85.4% | 81.8% |
| Sales and marketing | 12.1 | 11.1 | 12.1 | 11.4 | 11.1 | 10.6 | 14.0 | 13.9 |
| Research and development | 6.3 | 5.8 | 4.3 | 4.1 | 4.1 | 3.9 | 3.8 | 3.1 |
| General and administrative | 4.1 | 4.0 | 3.6 | 3.4 | 3.3 | 4.1 | 6.2 | 4.6 |
| EBIT | -0.9 | -0.5 | -0.7 | -0.6 | -0.1 | 0.9 | -0.9 | -0.6 |
| EBIT margin | -3.5% | -2.1% | -3.3% | -2.6% | -0.4% | 3.9% | -3.3% | -2.3% |
| Pre-tax income | -0.8 | -0.5 | -0.7 | -0.5 | 0.0 | 0.9 | -0.8 | -0.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 2.2 | -1.6 | -0.6 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | 4643.9% | | 0.0% | 0.0% |
| Net income | -0.8 | -0.5 | -0.7 | -2.7 | 1.5 | 1.6 | -0.8 | -0.5 |
| Net margin | -3.3% | -2.1% | -3.2% | -12.4% | 6.9% | 6.7% | -3.0% | -2.1% |
| |
| Diluted EPS | ($0.11) | ($0.07) | ($0.10) | ($0.36) | $0.17 | $0.18 | ($0.10) | ($0.07) |
| Shares outstanding (diluted) | 7.1 | 7.4 | 7.4 | 7.6 | 8.9 | 8.5 | 8.4 | 8.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|